Article info

other Versions

PDF
Randomised controlled trial
Fentanyl Pectin Nasal Spray reduces breakthrough cancer pain intensity compared with placebo in people taking at least 60 mg daily oral morphine or equivalent

Authors

  1. Correspondence to: Carol P Curtiss
    Master of Science in Pain Research, Education and Policy (MSPREP) Program, 73 James Street, Greenfield, MA 01301, USA; carol. curtiss{at}verizon.net
View Full Text

Citation

Curtiss CP
Fentanyl Pectin Nasal Spray reduces breakthrough cancer pain intensity compared with placebo in people taking at least 60 mg daily oral morphine or equivalent

Publication history

  • First published May 10, 2011.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.